OrbiMed Capital GP IV LLC

10% owner at ALEC; 10% owner at Principia Biopharma Inc.; 10% owner at Audentes Therapeutics, Inc., and 4 more

Sold, on record
$138M
Dollars the filings state
Form 4 sales
13
Latest Aug 7, 2019
Form 144 notices
0
Proposed sales
Companies
7
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Relypsa IncPlan not stated
    Sep 17 2014

    Sold 94,000 shares at $25.27 ($2.4M)

    OrbiMed Capital GP IV LLC, 10% owner

    Sold 1.1% of holdings ($226M position)8.9M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Relypsa IncPlan not stated
    May 18 +243 days

    Sold 1.5M shares at $34.13 ($49.7M)

    OrbiMed Capital GP IV LLC, 10% owner

    Sold 16.5% of holdings ($302M position)7.4M shares leftFiling

  3. 3 Form 4 sale Otonomy, Inc.Plan not stated
    Nov 19 +185 days

    Sold 138,398 shares at $28.62 ($4M)

    OrbiMed Capital GP IV LLC, Director

    Sold 6.1% of holdings ($64.6M position)2.1M shares leftFirst sale on recordFiling

  4. 4 Form 4 sale Otonomy, Inc.Plan not stated
    Nov 24 +5 days

    Sold 200,800 shares at $28.56 ($5.7M)

    OrbiMed Capital GP IV LLC, Director

    Sold 9.5% of holdings ($60.5M position)1.9M shares leftFiling

  5. 5 Form 4 sale Audentes Therapeutics, Inc.Plan not stated
    Sep 7 +653 days

    Sold 5,000 shares at $22.35 ($112k)

    OrbiMed Capital GP IV LLC, 10% owner

    Sold 0.1% of holdings ($107M position)4.8M shares leftFirst sale on recordFiling

  6. 6 Form 4 sale Audentes Therapeutics, Inc.Plan not stated
    Mar 12 +186 days

    Sold 156,431 shares at $34.97 ($5.5M)

    OrbiMed Capital GP IV LLC, 10% owner

    Sold 4.2% of holdings ($129M position)3.5M shares leftFiling

  7. 7 Form 4 sale Principia Biopharma Inc.Unusual
    May 21 +435 days

    Sold 1M shares at $30.25 ($30.3M)

    OrbiMed Capital GP IV LLC, 10% owner

    Sold 38.4% of holdings ($78.8M position)1.6M shares leftFirst sale on recordFiling

  8. 8 Form 4 sale ALECPlan not stated
    Aug 7 +78 days

    Sold 650,000 shares at $17.90 ($11.6M)

    OrbiMed Capital GP IV LLC, 10% owner

    Sold 18% of holdings ($64.8M position)3M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by OrbiMed Capital GP IV LLC
Source
Aug 7, 2019ALEC10% ownerForm 4 sale650,000$11.6M18.0%Plan not statedSEC
May 21, 2019Principia Biopharma Inc.10% ownerForm 4 sale1M$30.3M38.4%UnusualSEC
Mar 12, 2018Audentes Therapeutics, Inc.10% ownerForm 4 sale156,431$5.5M4.2%Plan not statedSEC
Sep 7, 2017Audentes Therapeutics, Inc.10% ownerForm 4 sale5,000$112k0.1%Plan not statedSEC
Nov 24, 2015Otonomy, Inc.DirectorForm 4 sale200,800$5.7M9.5%Plan not statedSEC
Nov 19, 2015Otonomy, Inc.DirectorForm 4 sale138,398$4M6.1%Plan not statedSEC
May 18, 2015Relypsa Inc10% ownerForm 4 sale1.5M$49.7M16.5%Plan not statedSEC
Sep 17, 2014Relypsa Inc10% ownerForm 4 sale94,000$2.4M1.1%Plan not statedSEC
Apr 9, 2014INTERCEPT PHARMACEUTICALS INCDirectorForm 4 sale81,305$26M4.7%Plan not statedSEC
Nov 15, 2011Anthera Pharmaceuticals IncDirector, 10% ownerForm 4 sale60,000$417k2.0%Plan not statedSEC
Jun 10, 2011Anthera Pharmaceuticals IncDirector, 10% ownerForm 4 sale100,000$810k3.2%Plan not statedSEC
May 26, 2011Anthera Pharmaceuticals IncDirector, 10% ownerForm 4 sale39,000$333kPlan not statedSEC
May 11, 2011Anthera Pharmaceuticals IncDirector, 10% ownerForm 4 sale129,400$936k3.8%Plan not statedSEC